Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Myeloma | 5 | 2025 | 98 | 1.890 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2020 | 42 | 0.710 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 386 | 0.620 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1356 | 0.410 |
Why?
|
| Interferon Regulatory Factors | 2 | 2024 | 31 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2024 | 116 | 0.380 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2024 | 637 | 0.300 |
Why?
|
| Osteolysis | 1 | 2025 | 15 | 0.240 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2025 | 36 | 0.240 |
Why?
|
| Ikaros Transcription Factor | 1 | 2024 | 18 | 0.230 |
Why?
|
| Thalidomide | 1 | 2024 | 28 | 0.230 |
Why?
|
| Proteasome Inhibitors | 1 | 2020 | 41 | 0.170 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 148 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 181 | 0.170 |
Why?
|
| Drug Synergism | 1 | 2020 | 315 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 687 | 0.160 |
Why?
|
| Bone Marrow | 1 | 2020 | 243 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 845 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 695 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 2 | 2023 | 1257 | 0.150 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2016 | 113 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 850 | 0.120 |
Why?
|
| Sputum | 1 | 2016 | 286 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 269 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 1144 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2020 | 4501 | 0.070 |
Why?
|
| Humans | 6 | 2025 | 114080 | 0.060 |
Why?
|
| Mice | 1 | 2020 | 14847 | 0.060 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2023 | 36 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 185 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 388 | 0.050 |
Why?
|
| Animals | 1 | 2020 | 31570 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2699 | 0.040 |
Why?
|
| Prognosis | 1 | 2025 | 3315 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2016 | 46 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 92 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 314 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2016 | 153 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 312 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1690 | 0.020 |
Why?
|
| Mass Screening | 1 | 2016 | 979 | 0.020 |
Why?
|
| Male | 2 | 2025 | 55420 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 12521 | 0.020 |
Why?
|
| Female | 1 | 2024 | 59349 | 0.010 |
Why?
|